What you need to know
Hackensack University Medical Center has launched an innovative surveillance program that screens individuals who are at high-risk for developing familial or hereditary pancreatic cancer.
This new initiative is the first of its kind in New Jersey. Eligible patients receive both an imaging test and a recently approved biomarker test that measures the immune system’s response to diseases in the blood.
Qualified patients will typically be seen within one week.
Screenings are available one morning each week at Hackensack University Medical Center between 9 a.m. and 12 p.m. These screenings will run from April 1, 2022 to September 30, 2022.
For an appointment call 551-996-3091.